ABSTRACT Objective: To demonstrate the clinical efficacy of autologous mitochondrial transplantation in preparation for translation to human application using an in vivo swine model.
Results: Levels of creatine kinase-MB isoenzyme and cardiac troponin I were significantly increased (P ¼ .006) in the vehicle-only group compared with the mitochondria group. Immune, inflammatory, and cytokine activation markers showed no significant difference between groups. There was no significant between-group difference in the AAR (P ¼ .48), but infarct size was significantly greater in the vehicle group (P ¼ .004). Echocardiography showed no significant differences in global function. Histochemistry and transmission electron microscopy revealed damaged heart tissue in the vehicle group that was not apparent in the mitochondria group. T2-weighted magnetic resonance imaging and histology demonstrated that the injected mitochondria were present for 4 weeks.
Conclusions:
Autologous mitochondrial transplantation provides a novel technique to significantly enhance myocardial cell viability following ischemia and reperfusion in the clinically relevant swine model. (J Thorac Cardiovasc Surg 2017;153:934-43)
Autologous mitochondrial transplantation decreases infarct size and preserves structure.
Central Message
Autologous mitochondrial transplantation provides a novel technique to significantly enhance myocardial cell viability following ischemia and reperfusion.
Perspective
Autologous mitochondrial transplantation is an efficacious cardioprotective therapy as demonstrated in the clinically relevant swine model. The isolation of autologous mitochondria can be performed in >30 minutes, within the time frame associated with cardiac surgery. Direct injection of autologous mitochondria into the area at risk significantly decreases markers of myocardial injury and infarct size.
See Editorial Commentary page 944.
In a series of previous studies, we have demonstrated that ischemia detrimentally alters mitochondrial structure, volume, calcium accumulation, complex activity, oxygen consumption, high-energy synthesis, mitochondrial-mediated intrinsic apoptosis, mitochondrial DNA integrity, and mitochondrial transcript and proteomics. [1] [2] [3] [4] [5] All of these events occur during ischemia and extend into reperfusion to severely compromise postischemic cellular viability. [1] [2] [3] 6 We have postulated that the augmentation or the addition of healthy mitochondria would allow for enhanced postischemic cellular viability and overcome the effects of stunning. In preliminary experiments, we used isolated perfused rabbit hearts and in situ blood-perfused rabbit hearts with 2 hours and 4 weeks of recovery. 7, 8 These investigations demonstrated that the transplantation of autologous mitochondria significantly decreases infarct size and significantly increases postischemic functional recovery. 7, 8 The transplanted mitochondria act both extracellularly and intercellularly to enhance oxygen consumption, increase high-energy phosphate synthesis, and induce cytokine mediators and proteomic pathways important for preserving myocardial energetics, cell viability, and enhanced postinfarct cardiac function. 8 The transplanted mitochondria are initially located in close proximity to myocardial cells and by 1 to 4 hours are integrated into the myocardial cells by actin-dependent endocytosis both as clusters and as individual mitochondria, where they rescue mitochondrial function and repair damaged mitochondrial DNA. 8, 9 The transplanted mitochondria are functional and viable for at least 4 weeks. 8, 9 The injected mitochondria do not elicit any immune or autoimmune response and are not proarrhythmic. 8 To allow for clinical relevance, here we report the results of our present study using a clinically relevant in situ large animal (swine) model. 
Surgical Protocol
The pig was sedated with telazol (2.2-4.4 mg/kg) and xylazine (1-2 mg/kg) through intramuscular injection. An endotracheal tube was placed, and general anesthesia was induced with isoflurane (induction, 3%; maintenance, 0.5%-2%). Core temperature was maintained at >36 C using a heating pad. Continuous invasive blood pressure through a femoral artery line and continuous pulse oximetry were monitored as well. Lidocaine (2 mg/kg) via continuous intravenous infusion was administered from the start of the thoracotomy, and heparin (100 U/kg) was given as a bolus before the snaring of the circumflex artery.
A small left thoracotomy was performed through the fourth intercostal space. The pectoralis major muscle was isolated, and 2 small muscle tissue samples (approximately 0.03 g) were removed using a #6 biopsy punch (Miltex, York, Pa) and stored for mitochondrial isolation under sterile conditions. The pericardium was opened, and the circumflex artery was located. A Prolene 3-0 suture (Ethicon, Somerville, NJ) was passed around the artery with a taper needle, and both ends of the tie were threaded through a small vinyl tube to form a snare. The artery was temporarily occluded by pulling the snare and fixed by clamping the tube with a mosquito clamp. RI was induced for 25 minutes and confirmed visually by ST-segment changes on the electrocardiogram. 8 
Mitochondrial Isolation
Mitochondria were isolated from the pectoralis major muscle. 10, 11 The isolated mitochondria were suspended in 1 mL of respiration buffer containing 250 mmol/L sucrose, 2 mmol/L KH 2 
and 1 mmol/L adenosine diphosphate. 8 Mitochondrial viability was assessed as described previously. 8 
Experimental Groups
After 24 minutes of RI, hearts were randomized to receive either eight 0.1-mL injections of sterile respiration buffer (vehicle) or eight 0.1-mL injections of sterile respiration buffer containing mitochondria (9.9 3 10 7 AE 1.4 3 10 7 /mL; 1.3 3 10 7 mitochondria per injection site) into the area at risk (AAR) (Figure 1 ). Each injection was delivered subendocardially into predesignated sites within the AAR using a sterile 1-mL insulin syringe with a 28-gauge needle. 7, 8 At 25 minutes of RI, the snare was released, and the pigs were then allowed to recover for 4 weeks. The Prolene suture-snare was trimmed and loosely tied and left in place to identify the AAR and infarct size. 8 The pericardium was closed, pleural air was evacuated, and the thoracotomy incision was closed. 8 Thirty minutes before the end of the procedure, a fentanyl patch (4 mg/kg, transdermal for 72 hours) was applied for pain prophylaxis.
Echocardiography
Echocardiography was performed using a Philips iE33 machine with a 5-MHz transducer (Philips Healthcare, Amsterdam, The Netherlands). The pigs were sedated and placed in the left lateral position. Left ventricular (LV) measurements were obtained on parasternal short-axis and long-axis images. Circumferential strain analysis was performed offline with TomTec 2D Cardiac Performance Analysis version 1.0 (TomTec Imaging Systems, Munich, Germany).
Blood Samples
Blood samples were collected in serum-separating tubes (BD Vacutainer SST; BD, Franklin Lakes, NJ) and stored at À80 C until use in biomarker analysis. 8 
Euthanasia
At 4 weeks of recovery, the pigs were sedated and anesthetized as described above. Then a sternotomy was performed, the heart was removed for biochemical and histological analysis, and the animal was euthanized by exsanguination.
Measurement of AAR and Infarct Size
The AAR and infarct size were measured as described previously. 12 
Histology and Electron Microscopy
Tissue samples from the AAR were dissected out and used for histology and electron microscopy analyses. Creatine kinase (CK-MB) and cardiac troponin I (cTnI) concentrations were estimated using a swine-specific enzyme-linked immunosorbent assay (Biocheck, Foster City, Calif; Life Diagnostics, West Chester, Pa).
Multiplex Assay
Serum samples from baseline and at 4 weeks of recovery were used for cytokine analysis using the Porcine Cytokine/Chemokine Kit and the TGF-b1 Array (EMD Millipore, St Charles, Mo). Multiplex assays were performed at Eve Technologies (Calgary, Alberta, Canada) using the Bio-Plex 200 system (Bio-Rad Laboratories, Hercules, Calif). All samples and standards were run in duplicate.
MRI
In a separate study, 4 pigs were used for MRI studies. Each pig was sedated and anesthetized, a mini-thoracotomy was performed, the heart was exposed, and RI was induced as described above. In brief, human cardiac fibroblasts were maintained in Fibroblast Medium-2 (ScienCell Reasearch Laboratories, Carlsbad, Calif) according to the supplier's directions and used for mitochondrial isolation. The mitochondria were labeled at 0 C with 10 mg of N-succinimidyl ester-functionalized 30-nm magnetic iron (II, III) oxide particles (Sigma-Aldrich, St Louis, Mo) in mitochondrial respiration buffer for 10 minutes, and then washed 3 times in the same buffer containing 1 mg/mL fraction V bovine serum albumin (Sigma-Aldrich).
After 24 minutes of RI, each heart received eight 0.1-mL injections of sterile respiration buffer containing human cardiac fibroblast mitochondria labeled with iron (1.0 3 10 8 /mL). The chests were closed, and the pigs were allowed to survive for 4 weeks. At 4 weeks, the hearts were removed and perfusion-fixed under constant pressure using 4% paraformaldehyde in phosphate-buffered saline (pH 7.4) and imaged on a BioSpec 70/30 USR 7-T MRI System (Bruker, Billerica, Mass). High-resolution 3-dimensional T2-weighted images were acquired using fast low-angle shot MRI.
Histology and Microscopy
Ventricles from fixed pig hearts used for T2*-weighted MRI were embedded in paraffin and sectioned for histological examination. Rehydrated tissue sections (5 mm thick) were subjected to antigen retrieval in 1 mmol/L ethylenediaminetetraacetic before incubation with the anti-mitochondria mouse monoclonal antibody [MTC02] (Abcam; ab3298) and anti-desmin rabbit monoclonal antibody (Abcam; ab32362). Primary antibodies were detected with species-appropriate secondary antibodies conjugated to Alexa Fluor 488 or 568 dyes (Thermo Fisher Scientific) and cross-stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) (Thermo-Fisher). Mounted sections were visualized on a FSX100 inverted fluorescence microscope (Olympus). Brightfield microscopy of sections stained using the Iron Stain Kit (Sigma-Aldrich, St. Louis MO) was performed with the same microscope.
Statistical Analysis
Statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC). To reduce the risk of false positive conclusions (type I errors) due to multiple testing, we applied the Bonferroni method using the multcomp package in R for vehicle versus mitochondria comparisons regarding CK-MB, CTnI, and infarct size. 13, 14 We did not adjust the P values for multiplicity regarding cytokine activation, because we did not expect group differences in these markers based on our hypotheses.
RESULTS

Body and Heart Weights
There was no significant difference (P ¼ .21) in animal body weight between the vehicle only (n ¼ 6) and mitochondria groups (n ¼ 6) after 4 weeks of recovery (Figure 2, A) . The median of the d for body weight was 1.9 kg (IQR, 0.9-5.6 kg) for the vehicle group and 3.6 kg (IQR, 2.6-5.1 kg) for the mitochondria group (P ¼ .62).
Mean LV weight following 4 weeks of recovery was 156.7 AE 7.4 g in the vehicle group and 158.8 AE 9.7 g in the mitochondria, a statistically nonsignificant difference (P ¼ .71) (Figure 2, B) .
Immune Response and Cytokine Activation
Immune and inflammatory response and cytokine activation, as measured by a multiplex assay (Milliplex Porcine Cytokine/Chemokine Kit, Millipore, St Charles, MO), showed no significant difference between groups after 4 weeks of recovery ( Table 1) .
Markers of Myocardial Injury
There were no significant between-group differences in CK-MB (median: vehicle, 66.9 [IQR, 58.8-71.9]; mitochondria, 63.9 [IQR, 58.1-70.1]; P ¼ .88) (Figure 3, A (Figure 3, B) .
At 3 days after surgery, CK-MB was significantly lower in the mitochondria group compared with the vehicle group (median: vehicle, 43.1 [IQR, 41.1-43.9]; mitochondria, 28.0 [IQR, 24.6-31.0]; P ¼ .006) (Figure 3, A) . Similarly, cTNi at 3 days after surgery was significantly lower in the mitochondria group (median: vehicle, 14.0 [IQR, 12.5-15.7] ; mitochondria, 7.9 [IQR, 7.7-8.8]; P ¼ .006) (Figure 3, B) . These results indicate significantly greater myocardial damage in the vehicle-only group compared with the mitochondria group.
Area at Risk and Infarct Size
There was no significant difference in the median AAR (% LV mass) between the 2 groups (vehicle: 28.5% [IQR, 25.6%-31.8%]; mitochondria: 33.2% [IQR, 25.0%-36.4%]; P ¼ .48) (Figure 4, A) .
Median infarct size (% AAR) was significantly greater in the vehicle group compared with the mitochondria group (13 (Figure 4, B) . Histochemistry and electron microscopy. Histochemical microscopy analysis of samples from the regional ischemic area showed significantly increased longitudinal and transverse interfibrillar separation in vehicle hearts compared with mitochondria hearts (Figure 4, C) . There was no alteration in collagen content observable between groups. Electron microscopy analysis showed mitochondrial damage and contraction bands in vehicle hearts that were not present in mitochondria hearts (Figure 4, D) . Electrocardiography. Electrocardiograms showed no difference between groups prior to ischemia; however, with the onset of regional ischemia, ST segment elevations (>1 mm) consistent with myocardial infarction were observed in all hearts ( Figure 5, A) . Electrocardiographic recordings at 120 minutes after injection of vehicle or mitochondria and at 4 weeks recovery showed no ventricular tachycardia, bradycardia, fibrillation, conduction system defects, mitral regurgitation or repolarization heterogeneity ( Figure 5, A) .
Echocardiography
Echocardiography showed no significant differences in the end-diastolic volume or parameters of global systolic function (ejection fraction, shortening fraction, and global circumferential strain) ( Figure 5, B) .
Myocardial Uptake of Mitochondria
To demonstrate mitochondrial uptake, pig hearts were injected with mitochondria isolated from human cardiac fibroblast cell cultures and then labeled with iron. Figure 6 , A shows MRI images of mitochondria uptake in pig hearts at 4 weeks after injection. Mitochondria were verified using antibodies specific to human mitochondria ( Figure 6, B) . Our results show that mitochondria are present for at least 4 weeks after injection in the pig heart.
DISCUSSION
Here we have demonstrated the efficacy of autologous mitochondrial transplantation in a clinically relevant porcine model. We used a mini-thoracotomy and obtained fresh nonischemic tissue from the pectoralis major; however, any nonischemic tissue source may be used. The mass of FIGURE 3. Creatine kinase-MB isoenzyme (CK-MB) (A) and cardiac troponin I (cTnI) (B) at day 1 and day 3 after surgery in the vehicle-only and mitochondria groups. Both CK-MB and cTnI were significantly decreased (P<.001) in mitochondria hearts compared with vehicle hearts at day 3. There was no significant difference between the 2 groups at day 1. Results are shown for n ¼ 6 in each group. Significant differences compared with vehicle are shown. *Significant differences compared with vehicle at P ¼ .006.
tissue required is small and is obtained using either scissors or a #6 biopsy punch. Dissection using electrocauterization is not recommended (personal communication).
To provide for clinical use, we have optimized the isolation of mitochondria. The isolation of mitochondria is rapid and can be performed in less than 30 minutes, a reasonable time frame within most cardiac surgical operations. The tissue required is small and can be obtained using a #6 dermatology punch. It is important to note that the source of mitochondria is unimportant in allowing for cardioprotection. In previous studies, we demonstrated that total, interfibrillar, and subsarcolemmal mitochondria isolated from the heart, liver, or skeletal muscle provide similar cardioprotection. 7 A step-by-step visual demonstration of the isolation procedure with quality assurance parameters is available elsewhere. 10, 11 We tested doses of 2 3 10 5 , 2 3 10 6 , 2 3 10 7 , and 2 3 10 8 mitochondria per 1 g of tissue (wet weight). These preliminary studies demonstrated no significant difference in the decrease in infarct size despite the differences in mitochondria number injected. In all of our studies, we suspended the mitochondria in a final volume of 1 mL and injected at 8 to 10 sites within the AAR. Mitochondrial concentrations >2 3 10 8 were not entirely suspended in 1 mL of buffer, and thus these concentrations were not used. 15 The number of mitochondria used in these studies was 9.9 3 10 7 AE 1.4 3 10 7 /mL, delivered as eight 0.1-mL injections within the area at risk (1.3 3 10 7 mitochondria per injection site). Injections were made using a sterile 1-mL insulin syringe with a 28-gauge needle. 7, 8 The injected mitochondria did not induce electrical disturbances. No ventricular tachycardia, bradycardia, fibrillation, conduction system defects, or repolarization heterogeneity was observed. 8 Our results also show that the injected mitochondria do not elicit any immune or inflammatory responses. There was no up-regulation of cytokines associated with the immune or inflammatory response seen in patients with acute heart transplantation rejection (interleukin [IL]-1, IL-4, IL-6, IL-12, IL-18, interferon-g-inducible protein 10, and macrophage inflammatory proteins 1a and 1b), and there was no overproduction of transforming growth factor b1, b2, or b3. 16, 17 Of importance, our findings demonstrate that the intramyocardial injection of autologous mitochondria into the AAR of the ischemia/reperfusion-injured heart significantly decreases CK-MB and cTnI concentrations and significantly decreases infarct size. The effects of mitochondrial injection on infarct size persist for at least 4 weeks after injection.
To demonstrate that the transplanted mitochondria are present in the myocardium for 4 weeks after injection, we used a separate group of pigs for mitochondria experiments as described above, but using xenogeneic human mitochondrial isolated from human cardiac fibroblast primary cell cultures. This use of human mitochondria in a pig model allowed for the differentiation between native pig mitochondria and transplanted human mitochondria based on immune reactivity to a monoclonal anti-human mitochondria antibody in postmortem histological tissue analysis. Our results show that injected mitochondria are taken up by myocardial cells and are present in the myocardium for at least 4 weeks after injection. In a separate study, we reported that the mean fraction of mitochondria taken up by the myocardium was 76.18% AE 11.85%. 18 The mechanisms through which the mitochondrial transplantation provides for cardioprotection involve energy synthesis, cell rescue, replacement of damaged mitochondrial DNA, up-regulation of protein pathways for the mitochondrion and the generation of precursor metabolites for energy and cellular respiration, and up-regulation of cytokines shown to play key roles in angiogenesis, arteriogenesis, immunomodulation, progenitor cell migration, prevention of apoptosis, and enhanced cell salvage and postischemic functional recovery. [7] [8] [9] These mechanisms act at the time of injection and persist in the myocardium for at least 4 weeks (the duration of our present investigation).
Limitations
This study used a model of acute myocardial infarction in which treatment is immediate and without added complications. In this laboratory setting, the rescue of myocardial cells following ischemia and associated stunning is optimal, and thus our results may be overly optimistic in a clinical setting in which there may be a delay in the response to treatment.
In this study, we used the circumflex artery rather than the left anterior descending (LAD) artery for ligation. We did so to allow for relevant evaluation of the efficacy of autologous mitochondrial injection for cardioprotection. Initial studies using the LAD demonstrated that the animals receiving vehicle only were severely injured and did not survive. To avoid death as an endpoint, we reasoned that a less severe but still clinically relevant injury would provide more relevant and useful data.
We were unable to demonstrate any significant betweengroup differences in global myocardial function using serial parasternal echocardiography. 19 The use of parasternal echocardiography proved difficult, given the small and irregular echocardiology window in the pig owing to its large and extended sternum and large muscle mass. These anatomic features hinder consistent measurements and comparison of results between groups. 20 In previous studies, we used epicardial echocardiography to demonstrate differences between groups. In the present study, we did not use epicardial echocardiography, to avoid possible induction of fibrillation in the more sensitive pig heart. These differences most likely contributed to our inability to detect significant differences in end-diastolic volume or parameters of global systolic function despite the significant differences in infarct size between hearts receiving vehicle only and those receiving autologous mitochondria.
CONCLUSIONS
As demonstrated in our clinically relevant swine model, autologous mitochondrial transplantation is an efficacious cardioprotective therapy. The isolation of mitochondria is rapid and can be performed within the clinically relevant time frame associated with cardiac surgery. No proarrhythmic, immune, or inflammatory reactions were observed following mitochondrial transplantation. The transplanted mitochondria remained in the myocardium for at least 4 weeks after injection.
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